DOCSLIB.ORG

National Council of University Research Administrat

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
National Council of University Research Administrat Thank you! NCURA Region III wishes to thank our sponsors for their support! Corporate - Gold Level Corporate – Bronze Level Institutional 2 Program Committee Chair Jill Frazier Tincher, University of Miami Cynthia Hope, The University of Alabama Danielle McElwain, University of South Carolina Robyn Remotigue, Mississippi State University Riddick Smiley, East Carolina University Greg Thompson, Florida State University Mo Valentine, University of Arkansas for Medical Sciences Maria Valero-Martinez, University of Miami Michelle Vazin, Vanderbilt University Jeanne Ware, New College of Florida “Somewhere, something incredible is waiting to be known.” Carl Sagan 3 Welcome to NCURA Region III’s 2009 Meeting TABLE OF CONTENTS Page # Agenda 5 Sunday Schedule 8 Monday Schedule 14 Tuesday Schedule 22 Wednesday Schedule 32 Regional Committees 33 Hotel Maps 37 Program At-a-Glance 39 4 Agenda Tuesday, May 5, 2009 Continental Breakfast 7:30am – 9:00am Sunday, May 3, 2009 Morning Concurrent Sessions & Discussion Groups Registration 7:00am - 5:30pm 9:00am - 10:15am Continental Breakfast 7:00am - 8:30am Morning Break 10:15am - 10:30am Full-day Workshops Late Morning Concurrent Sessions 8:30am - 5:00pm & Discussion Groups Morning Workshops 10:30am - 11:45am 8:30am - 12:00pm Lunch 12:00pm - 1:00pm Morning Break 10:00am - 10:15am Afternoon Concurrent Sessions Lunch 12:00pm - 1:00pm 1:30pm - 2:45pm (Workshop participants only) Afternoon Break 2:45pm - 3:00pm Afternoon Workshops Late Afternoon Concurrent Sessions 1:30pm - 5:00pm & Discussion Groups Afternoon Break 3:00pm – 3:15pm 3:15pm – 4:30pm Orientation For Newcomers 5:15pm – 6:00pm Dinner/Party Welcome Reception 6:00pm - 10:00pm 6:00pm - 7:00pm Poker Run for Fun Hospitality Suite Open 6:00pm – 10:00pm 8:00pm – 12:00am Hospitality Suite Open 8:00pm – 12:00am Monday, May 4, 2009 Continental Breakfast 7:30am - 9:00am Welcome and Keynote Address Wednesday, May 6, 2009 9:00am - 10:30am Breakfast & Regional Business Morning Break 10:30am - 10:45am Meeting Morning Concurrent Sessions 8:30am – 10:00am 10:45am - 12:00pm Panel Discussion Lunch 12:00pm - 1:00pm 10:15am – 11:30am Afternoon Concurrent Sessions & Adjourn 11:45am Discussion Groups 1:30pm - 2:45pm Afternoon Break 2:45pm - 3:00pm Late Afternoon Concurrent Sessions 3:15pm – 4:30pm Hospitality Suite Open 5 8:00pm – 12:00am Agenda Hospitality Suite Activities Meet new and existing colleagues and have some fun! The suite will be open Sunday through Tuesday, 8:00 p.m. – 12:00 a.m. Ambassador Suite, 6th Floor Main Building School Spirit! Sunday, May 3, 2009 Caps, t-shirts, sweats, etc.… Represent your school Wanna Play? Monday, May 4, 2009 Board games & card games Cinco de Mayo! Tuesday, May 5, 2009 How low can you go? Special thanks and appreciation to our Hospitality Suite Sponsor, American Appraisal 6 Thank you Volunteers! The 2009 Region III Meeting could not have occurred without the 2009 Program Committee, the Regional Officers, Regional Committees, the workshop faculty, concurrent session speakers, discussion group leaders, moderators and the countless volunteers who have assisted with registration desk, audio visual assistance, hospitality suite, fundraising, dinner groups, etc. A special thank you to all of you for your contributions!! 7 Sunday, May 3, 2009 Registration 7:00 a.m. - 5:30 p.m. Registration Desk Continental Breakfast 7:00 a.m. - 8:30 a.m. St. Andrews Ballroom Full-day Workshops 8:30 a.m. - 5:00 p.m. Morning Workshops 8:30 a.m. - 12:00 p.m. Morning Break 10:00 a.m. - 10:15 a.m. St. Andrews Ballroom Foyer Lunch 12:00 p.m. - 1:00 p.m. St. Andrews Ballroom Afternoon Workshops 1:30 p.m. - 5:00 p.m. Afternoon Break 3:00 p.m. – 3:15 p.m. St. Andrews Ballroom Foyer 8 Workshops Sunday, May 3, 2009 8:30 a.m. – 5:00 p.m. Full-Day Workshops W1 “Increasing Transfer in Training: Successful Approaches to Training for Research Administrators” Location: St. Andrews Ballroom I Presenters: Sam Gannon, Manager, Education & Training, Vanderbilt University Medical Center In this full day train the trainer workshop participants will become knowledgeable about adult learning styles and discuss the barriers to transfer in research administrator education and training programs and how to overcome them. The workshop will introduce and demonstrate strategies to engage faculty, students and staff members in training and how to measure effectiveness. Participants will learn to use the Understanding by Design methodology in approaching their training classes and will be given some general design guidelines for PowerPoint and materials/handouts. Bring materials from a current class or one you're planning so that we may workshop it in the afternoon and you can return to work with a new class that's ready for success. W2 “Introduction to Pre-Award” Location: St. Andrews Ballroom II Presenters: Robyn Remotigue, Assistant Director, Mississippi State University, Charles Patterson, Associate Vice President for Research, Georgia Southern University and Kacey Strickland, Director, Office of Regulatory Compliance of Mississippi State University This workshop will provide a broad overview of various topics that involve fundamental pre-award activities in sponsored projects administration, designed for anyone new to research administration or for those who just need a refresher. This session will cover the many diverse responsibilities of pre-award administration, including rules, regulations and agreements; research integrity and compliance; electronic research administration; office models and organization; proposal development, review and submission; monitoring and compliance for research subjects; hot topics in research administration and more. Come prepared to interact, learn and share your experiences in an enjoyable setting! 9 Workshops Sunday, May 3, 2009 8:30 a.m. – 12:00 p.m. Morning Workshops W3 “The Complete Award Administrator: A-21, A-110, A-133 and Good Coffee” Location: St. Andrews Ballroom V Presenters: Cynthia White, Director, Office of Sponsored Programs, Belmont University Why do some proposals specialist and department administrators seem to make fewer errors and prevent more problems than their colleagues? Despite tea drinkers and other outliers, research indicates that high quality coffee is a significant factor. However, there is also strong evidence suggesting that a mastery of applicable OMB Circulars gives a research administration professional a grasp of the big picture, e.g., the regulatory framework undergirding the entire grant lifecycle. Understanding how each phase of the grant cycle relates to the next empowers award administrators to foresee and prevent future problems for themselves, PIs and their administrative colleagues. This session will review the parts of the circulars which are particularly helpful to pre-award and departmental staff with the goal of decreasing unreported program income, unidentified cost sharing, disguised vendor contracts and stuffed crust pizza in proposal budgets. This information is also useful to the post award administrator with no clue what those non-financial folks are drinking that would keep them from identifying such glaring potential problems. With fewer problems to untangle, fewer disgruntled guests will drink your expensive coffee. In this budget environment that's a great learning outcome. W4 “Negotiating for Mutual Satisfaction” Location: St. Andrews Ballroom VI Presenters: Barbara Gray, Director, Grants and Contracts, Valdosta State University Old style, hard tactic techniques used to negotiate commodity prices, and even the newer "win-win" strategies in which both sides come away from the table with something they can live with, are not the most appropriate approaches to negotiating, whether the negotiation is related to a sponsored project agreement, an issue with a faculty member, a problem in the sponsored programs office, or a conflict with another university office. Principled negotiation can help you establish and manage positive relationships with others. More importantly, negotiating for mutual satisfaction, in which both parties derive greater benefit than either initially thought possible, can help you sustain long-term partnerships that can be applied widely in negotiating for mutual satisfaction, including establishing a professional tone and approach, preparing for and managing the negotiation, and building a bigger "pie" for the parties. Participants will complete several exercises, including a role play negotiation when a university project funded by start-up company goes away. 10 Workshops Sunday, May 3, 2009 1:30 p.m. – 5:00 p.m. Afternoon Workshops W5 “Sub-awards and Monitoring From Writing the Proposals to Project Closeout- How to Manage Risk” Location: St. Andrews Ballroom V Presenters: Rob Roy, Director of Business Operations, Georgia Institute of Technology and Anita McKinney, Contracting Officer, Georgia Institute of Technology One of the fastest growing areas in research administration is inter-institutional collaborations. This workshop will be a guided discussion with participants about sub-awards starting with a look at the National Sub-award Model Agreement Form, progressing through roles and responsibilities, things to keep in mind when writing a proposal, to effective monitoring procedures, and closeouts. The workshop will look at sub-awards and sub-recipient monitoring from a departmental perspective identifying areas of potential risk as well as auditing guidance from various sources including recent audit findings. W6 “Beyond the Fundamentals of Post
Load more

Recommended publications
  • FELLOW, ONCOLOGY RESEARCH – Southern Research, Birmingham, AL SOUTHERN RESEARCH, a Nonprofit, Scientific Research Organization
    FELLOW, ONCOLOGY RESEARCH – Southern Research, Birmingham, AL SOUTHERN RESEARCH, a nonprofit, scientific research organization, is seeking an outstanding scientist for the position of Fellow in the field of Oncology The position is equivalent to the rank of Assistant, Associate or Full Professor in an academic institution (depending on the incumbent’s experience) and offers a unique opportunity to join the growing research team at Southern Research. Southern Research promotes a collaborative research environment to facilitate the multidisciplinary nature of drug discovery, accomplished internally through integration of basic biology, translational research, chemistry, and high-throughput screening, and also through its regional, national and international academic and industrial partnerships. The Oncology Department is focused on combining novel basic research and discovery to identify next generation cancer therapeutics. In contrast to traditional academic environments, Southern Research’s Oncology Department offers the opportunity for the individual to focus exclusively on engaging in research and professional development activities for advancement and development of new research ideas, support for the research team, and overall ability to make innovative advances in scholarly work portfolios. The Fellow of Oncology requires distinguished scholarship, including 10+ years of research experience in the field of oncology from any one of a number of concentrations, including cancer immunotherapy, cancer stem cells, cancer genomics, cancer pharmacogenomics, cancer microbiome, cancer pharmacology, genomic instability, or closely related area, and an ongoing extramurally-funded research program related to drug discovery. Southern Research desires a collegial, collaborative and outstanding scientist to cultivate mentorship and lead research within the Oncology Department. To be considered, applicants must: 1) possess a Ph.D., M.D.
    [Show full text]
  • Pathology in Focus
    PATHOLOGY IN FOCUS Vol 5 Issue 3 August 2011 Message from the Chair The start of the many faculty candidates will be several Department of Pathology Inside this issue: new school year visiting UAB and I hope that you will investigators are tentatively Faculty Profile: Dr. Hébert- 2-3 once again brings be able to attend as many candi- scheduled to move this fall into Magee many new faces date seminars as possible. renovated laboratory space in the to the Department Wallace Tumor Institute. These APC Teaching Awards 3-4 of Pathology. In A number of construction and new facilities will permit further Where Are They Now? 4 addition to the building renovation projects are expansion of cancer related re- Spotlight on Administration 5 annual influx of new residents, underway in the department and search in our department and help fellows and graduate students, several are nearing completion. I us to recruit additional outstanding New Changes in HIT 5-6 several new faculty members will am optimistic that by the time you clinicians and investigators to UAB. 6-7 From the Chief Residents be joining various divisions over read the next quarterly newsletter, From the Graduate Students 7-8 the next few months. Look for new the Anatomic Pathology Division faculty profiles in this and upcom- faculty, staff, and services cur- Best wishes, New Faculty Recruits 8 ing issues of our newsletter. Our rently housed in the Kracke Build- Kevin A. Roth, M.D., Ph.D. Pathology Grant Awards 9 aggressive recruitment strategy ing will all be moved to newly com- will continue through the fall as pleted facilities in PD6A.
    [Show full text]
  • Bio-Tech/Life Science Industry Profile
    ALABAMA’S BIO-INDUSTRY OVERVIEW Alabama’s multifaceted biosciences industry generates $7.3 billion in economic activity BIOSCIENCES annually while supporting 780 companies and nearly 48,000 direct and indirect jobs GENERATED across the state, according to an analysis by researchers at the University of Alabama. $7.3 BILLION Alabama’s biosciences sector is a robust combination of research institutions, labs, medical devices, innovative startups, pharmaceutical manufacturers, and more. IN ECONOMIC ACTIVITY BIO-INDUSTRY INNOVATION SUPPORTING Bioscience-Related U.S. Patents Bioscience-Related U.S. Patents 2014-2017 by Segment 2014-2017 780 53 Agricultural Chemicals COMPANIES 2014 161 Biochemistry 134 Bioinformatics & Health IT 9 2015 142 Biological Sampling & Analysis 42 Drugs & Pharmaceuticals 335 2016 159 Genetics 19 2017 141 Medical & Surgical Devices 240 Microbiology & Enzymes 37 Novel Plant Variants 14 Source: Bio.org, Alabama: Investment, Innovation and Job Creation in a Growing U.S. Bioscience Industry 2018 www.bio.org/value-bioscience-innovation-growing-jobs-and- improving-quality-life-2018 Bioscience Academic R&D Expenditures 48,000 $ Millions FY 2016 DIRECT AND Health Sciences $373.3 INDIRECTJOBS Biological & Biomedical $152.1 ACROSS THE Sciences Agricultural STATE Sciences $72.0 Other Life $29.4 Sciences Bioengineering Source: BioAlabama / Biomedical $4.0 Engineering www.edpa.org / (205)943-4700 / ALABAMA’S BIO-INDUSTRY NATIONAL INSTITUTES OF HEALTH FUNDING $450,000 NIH Funding ($ thousands) Alabama’s Top NIH-funded Research Institutions $400,000 $350,000 University of Alabama at Birmingham $300,000 University of South Alabama $250,000 Auburn University $200,000 University of Alabama $150,000 Southern Research Institute $100,000 $294,964 $298,159 $280,132 $228,361 $350,735 $391,578 $253,111 HudsonAlpha Institute of Biotechnology $50,000 $254,389 Source: National Institutes of Health, NIH Awards by Location & $- Organization - U.S.
    [Show full text]
  • Peter Jeffrey Conn
    Peter Jeffrey Conn 2806 Acklen Ave. Nashville, TN 37212 Professional Address P. Jeffrey Conn, Ph.D. Lee E. Limbird Professor of Pharmacology Director, Vanderbilt Center for Neuroscience Drug Discovery Department of Pharmacology Vanderbilt University 2215 Garland Avenue 1215-D Light Hall Nashville, TN 37232-6600 Phone: (615) 936-2478 Fax: (615) 343-3088 E-mail: [email protected] Education 1977 – 1981 B.S. Lee University, Cleveland, Tennessee (Psychology) (Magna Cum Laude) 1981 – 1982 University of Cincinnati, Cincinnati, Ohio (Physiological Psychology) 1982 – 1986 Ph.D. Vanderbilt University, Nashville, Tennessee (Pharmacology) Professional Training and Experience 1986 Research Associate, Department of Pharmacology, Vanderbilt University School of Medicine, Nashville, TN 1986 – 1988 Postdoctoral Fellow, Department of Pharmacology, Yale University School of Medicine, New Haven, CT 1988 Visiting Lecturer, Yale College, Yale University, New Haven, CT 1988 – 1994 Assistant Professor, Department of Pharmacology, Emory University School of Medicine, Atlanta, GA P. Jeffrey Conn – Curriculum Vitae Page 2 1994 – 1999 Associate Professor, Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 1999 – 2000 Professor, Department of Pharmacology, Emory University School of Medicine, Atlanta, GA 2000 – 2003 Senior Director and Head, Department of Neuroscience, Merck Research Laboratories, Merck and Company, West Point, PA 2000 – 2005 Adjunct Professor, Department of Pharmacology, Emory University School of Medicine, Atlanta,
    [Show full text]
  • Antibiotic and Antibacterial Vaccine Development Services
    06/01/18 Antibiotic and Antibacterial Vaccine Development Services www.SouthernResearch.org/Drug-Development Contents Why choose Southern Research? ................................................................................................................. 4 in vitro Testing Services................................................................................................................................ 5 B0101 Minimum Inhibitory Concentration (MIC): ........................................................................................ 5 B0102 Minimum Bactericidal Concentration (MBC): .................................................................................... 5 B0103 Time-kill Assay: .................................................................................................................................. 5 B0104 Resistance Frequency Determination: ............................................................................................... 5 B0105 Post-antibiotic Effect (PAE): ............................................................................................................... 6 B0106 Serum and B0107 Protein Sensitivity: ............................................................................................... 6 B0108 Serum and B0109 Protein Binding: .................................................................................................... 6 B0110 Plasma and B0111 Microsome Stability: ........................................................................................... 6 B0112
    [Show full text]
  • Improved Orthopedic Surgical Frame
    Improved Orthopedic Surgical Frame ALLIANCE FOR INNOVATIVE MEDICAL TECHNOLOGY – AIMTECH / TRAUMA Surgical retraction frame that can be quickly repositioned for procedures utilizing multiple surgical windows, especially for unstable pelvic fractures. Frame designed to be radio-lucent for use with X-ray procedures without needing to be disassembled or moved. ■■Technical Readiness Level ■■Inventors TRL 5 (Component validation in a relevant environment)— • Jason Lowe M.D., UAB Department Surgical frame made from carbon fiber components and of Orthopedic Surgery tested in a cadaver lab. • Alan Eberhardt, Ph.D., UAB Department ■■Competitive Advantages + Differentiation of Biomedical Engineering • Jason Lueck, Engineering, Southern Research Requires fewer surgical technicians to manually retract tissues, potentially reducing complications due to technician ■■Market Overview retraction error and fatigue. Reduced surgical time by Estimated 7M orthopedic fractures annually (US). Pelvic leaving frame in place during X-ray procedures. fractures represent 3%-6% of all fractures, and unstable ■■Intellectual Property Status fractures represent up to 20% of all pelvic fractures. ~63k. Patent Application WO 2016/611837 A1. PLEASE CONTACT Stacey Kelpke / Southern Research [email protected] / 205.581.2879 ABOUT SOUTHERN RESEARCH ABOUT UAB Founded in 1941 in Birmingham, Alabama, Southern Research is a scientific Known for its innovative and interdisciplinary approach to education at and engineering research organization that conducts preclinical drug both the graduate and undergraduate levels, the University of Alabama at discovery and development, advanced engineering research in materials, Birmingham is an internationally renowned research university and academic systems development, and energy and environmental technologies medical center, as well as Alabama’s largest employer, with some 23,000 research.
    [Show full text]
  • Alabama's Medical Device Industry Overview
    ALABAMA’S MEDICAL DEVICE INDUSTRY Baxter Incorporated makes OVERVIEW hemodialysis dialyzers, a high‐tech blood ‐filtering product used in kidney dialysis Alabama is known for its healthcare and biotechnology industries. The state has treatment. The facility is located in seven research universities, a highly accomplished contract research organization, a Opelika. biotechnology research institute, and dozens of life sciences companies. Access to talent, partnerships with higher education and industry, a low cost of living and BioHorizons, one of the fastest‐growing doing business creates a rich ecosystem for the medical device industry. global implant and biologics companies in the medical device industry, is located in Birmingham. Its porolio includes dental implants, instruments and biologics products. Southern Research (SR), a contract research organizaon with seven FDA‐ approved drugs on the market and campuses devoted to life science, engineering research and development, is located in Birmingham. Steris Corporaon has a global specialty HIGHLIGHTS services operaon headquartered in Birmingham. In 2014, Steris acquired IMS, a surgical device restoraon and Southern Research and the University of Alabama at Birmingham partnering through consulng company in Birmingham. the AIMTech project to develop life-changing medical devices. Over 600 bioscience companies, including 54 medical device and equipment Orchid Orthopedic Soluons is a world companies, employ approximately 1,600, according to U.S. Bureau of Labor Statistics leading medical device contract design data from 2014 Batelle/BIO report. and manufacturing company. The Average annual wage for the medical device and equipment industry is $55,958, facility, located in Arab, manufactures according to U.S. Bureau of Labor Statistics data from 2014 Batelle/BIO report.
    [Show full text]
  • NIH Public Access Author Manuscript Curr Pharm Biotechnol
    NIH Public Access Author Manuscript Curr Pharm Biotechnol. Author manuscript; available in PMC 2013 July 19. NIH-PA Author ManuscriptPublished NIH-PA Author Manuscript in final edited NIH-PA Author Manuscript form as: Curr Pharm Biotechnol. 2010 November ; 11(7): 764–778. Open Access High Throughput Drug Discovery in the Public Domain: A Mount Everest in the Making Anuradha Roy, Peter R. McDonald, Sitta Sittampalam, and Rathnam Chaguturu* High Throughput Screening Laboratory, Institute for Advancing Medical Innovations, University of Kansas, Lawrence, KS 66047, USA Abstract High throughput screening (HTS) facilitates screening large numbers of compounds against a biochemical target of interest using validated biological or biophysical assays. In recent years, a significant number of drugs in clinical trails originated from HTS campaigns, validating HTS as a bona fide mechanism for hit finding. In the current drug discovery landscape, the pharmaceutical industry is embracing open innovation strategies with academia to maximize their research capabilities and to feed their drug discovery pipeline. The goals of academic research have therefore expanded from target identification and validation to probe discovery, chemical genomics, and compound library screening. This trend is reflected in the emergence of HTS centers in the public domain over the past decade, ranging in size from modestly equipped academic screening centers to well endowed Molecular Libraries Probe Centers Network (MLPCN) centers funded by the NIH Roadmap initiative. These centers facilitate a comprehensive approach to probe discovery in academia and utilize both classical and cutting-edge assay technologies for executing primary and secondary screening campaigns. The various facets of academic HTS centers as well as their implications on technology transfer and drug discovery are discussed, and a roadmap for successful drug discovery in the public domain is presented.
    [Show full text]
  • Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID- 19 Vaccine Collaboration
    June 18, 2020 Tonix Pharmaceuticals and Southern Research Announce Expansion of COVID- 19 Vaccine Collaboration Plan to Produce Blueprint of How the Human Immune System Responds to Infection Caused by SARS-CoV-2, the Virus that Causes COVID-19 Results Expected to Support Tonix’s Anticipated Regulatory Filings for TNX-1800, a Live Replicating Virus Vaccine Designed to Elicit T Cell Immunity in Addition to Antibodies NEW YORK, June 18, 2020 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (Tonix or the Company), a clinical-stage biopharmaceutical company, announced today an expansion of its strategic collaboration with Southern Research to include a study of T cell immune responses to SARS-CoV-2 in volunteers who have recovered or remain asymptomatic after exposure to COVID-19. The research is part of an ongoing and broader collaboration between Tonix and Southern Research to develop and conduct animal testing of Tonix’s TNX-1800, which is a live replicating virus vaccine designed to protect against COVID-19. The data will support the interpretation of animal trial results with TNX-1800, which are expected in the fourth quarter of 2020 and subsequent human trials. “More than 200 years of vaccine experience, beginning with Dr. Edward Jenner’s landmark discoveries with horsepox and cowpox vaccines, have shown that T cell eliciting vaccines are particularly effective against viruses,” said Seth Lederman, M.D., President and CEO of Tonix. “We believe that protective vaccines against the SARS-CoV-2 virus will be similar in that regard. The data we plan to collect from recovered and asymptomatic COVID-19 volunteers will inform vaccine development on how to safely provide to vaccine recipients the same immune responses that others got from recovering from actual CoV-2 infection.
    [Show full text]
  • Nih Funding at Work in Alabama
    Follow us on Twitter @UMR4NIH NIH FUNDING AT WORK IN ALABAMA QUICK FACTS NIH awarded $383.5 MILLION1 in grants and contracts during FY2020 that directly supported 6,008 JOBS2 and $922 MILLION2 economic activity in Alabama. The highest annual occurrences of disease deaths in Alabama are due to CANCER (10,632 lives lost), HEART DISEASE (13,473 lives lost) and STROKE (3,088 lives lost).3 Top-funded research institutions in Alabama include:1 University of Alabama at Birmingham Southern Research Institute Hudson-Alpha Institute for Biotechnology University of South Alabama Auburn University Jobs Supported by NIH Economic Activity Supported:2 Biopharmeceutical Industry Jobs:4 Biopharmeceutical Industry Extramural Research:2 Businesses:4 6,008 $922M 11,948 1,092 UMR is a coalition of leading research institutions, patient and health advocates and private industry seeking steady and sustainable increases in funding for the National Institutes of Health in order to save and improve lives, advance innovation and fuel the economy. The coalition members are: AdvaMed • Alzheimer's Association • American Association for the Advancement of Science • American Cancer Society Cancer Action Network • Association of American Universities • Association of Public and Land Grant Universities • BD • Boston University • Corning • Harvard University • Johns Hopkins University • Johnson & Johnson • Massachusetts Institute of Technology • Northwestern University • PhRMA • Stanford University • Thermo Fisher Scientific • University of Pennsylvania • Vanderbilt University • Vanderbilt University Medical Center • Washington University in St. Louis 1. National Institutes of Health (NIH), NIH Awards by Location & Organization, U.S. FY2020 2. United for Medical Research Original Data - U.S. FY2020 3. Centers for Disease Control, "National Vital Statistics Report: Deaths: Final Data for 2018" Page 58.
    [Show full text]
  • TABLE 46. Federal Obligations for Science and Engineering R&D And
    TABLE 46. Federal obligations for science and engineering R&D and R&D plant to the 100 nonprofit institutions receiving the largest amounts, ranked by total amount received in FY 2009: FY 2001–09 (Dollars in thousands) Rank Institution 2001 2002 2003 2004 2005 2006 2007 2008 2009a All institutions 3,933,088 5,278,301 5,720,427 6,083,714 6,243,849 6,572,639 6,872,498 6,471,044 8,321,301 1 MA General Hospital 219,979 250,440 294,794 296,765 301,630 311,202 321,660 316,173 382,563 2 MITRE Corp. 212,576 226,312 187,210 284,478 282,943 307,239 305,360 322,882 344,765 3 Brigham and Women's Hospital 176,312 207,465 220,221 233,907 250,949 239,456 258,176 254,107 324,852 4 Battelle Memorial Institute 36,710 98,854 122,844 137,764 125,405 194,989 345,463 307,733 302,914 5 Fred Hutchinson Cancer Research Ctr. 173,490 175,631 208,055 213,461 202,272 253,460 231,817 224,163 263,980 6 IIT Research Institute 2,783 58,020 64,948 126,516 118,405 131,519 134,031 142,003 232,359 7 Mayo Foundation 117,017 145,499 163,077 208,152 181,118 188,966 192,570 187,372 214,139 8 Beth Israel Deaconess Medical Ctr. 103,331 101,072 106,555 114,331 125,781 126,403 115,594 114,981 152,205 9 Dana-Farber Cancer Institute 96,563 103,973 122,344 125,490 112,519 128,455 141,002 140,217 150,944 10 Associated Universities Inc.
    [Show full text]
  • Chapter 9 Growing Economic Base Industries $395K
    $500K Chapter 9 $395K Growing Economic Base Industries $300K $200K $100K PERSONAL VISION STATEMENTS $33K “Having a culture and tools 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2-BEDROOM 3-BEDROOM 4-BEDROOM ALL PROPERTIES that allow for innovation and entrepreneurship.” “Economic stability for residents, businesses, and persons looking to do business in the city...” 9.1 CITY OF BIRMINGHAM COMPREHENSIVE PLAN PART IV | CHAPTER 9 GROWING ECONOMIC BASE INDUSTRIES GOALS POLICIES FOR DECISION MAKERS A diversified, knowledge-driven economy, • Target city resources and support to existing and emerging economic base anchored by established and emerging industries. industry sectors, built on the city’s competitive strengths, and providing job • Support the development of a diverse economy that provides a wide range of opportunities in a range of occupations employment opportunities and shields the city from over-dependence on any single and skill levels. industry. • Leverage city resources through collaboration with key partners in the private and nonprofit sectors. • Engage with the business community to ensure that city policies are responsive to business needs. • Advocate for state policies and investments that support the city’s economic development. • Collaborate at the regional level when regional action is required to advance the city’s economic interests. A city and its government that are focused • Strive to create and maintain an award-winning educational system, both in the on economic development. Pre-K and K-12 systems and in higher education. • Ensure that the City’s workforce development programs are meeting the needs of its citizens and of current and future employers.
    [Show full text]